<DOC>
	<DOCNO>NCT02236247</DOCNO>
	<brief_summary>Study aim compare I ( f ) inhibitor ivabradine placebo strategy heart rate control patient decompensated heart failure ( DHF ) .</brief_summary>
	<brief_title>Control Sinus Node Tachycardia Additional Therapy Patients With Decompensated Heart Failure</brief_title>
	<detailed_description>Sympathetic hyperactivity consequent increase heart rate ( HR ) physiological response low cardiac output patient decompensated heart failure ( DHF ) . However , elevate HR may become inappropriate patient , increase myocardial oxygen demand decrease diastolic filling time might lead hemodynamic deterioration , ventricular dysfunction ( tachycardiomyopathy ) clinical deterioration . Studies show elevate HR predictor poor prognosis DHF . Subanalyses large clinical trial use beta blocker ( BBs ) demonstrate adequate control HR correlate well outcome patient stable chronic heart failure ( HF ) . However , use BBs patient DHF limit due negative inotropic hypotensive effect drug . As alternative BBs , ivabradine show increase survival patient chronic stable systolic HF . Compared BBs , ivabradine advantage `` pure '' negative chronotropic effect , effect myocardial contractility peripheral vascular resistance . Despite inhibition I ( f ) validate therapeutic option patient stable HF , study available strategy patient DHF . We hypothesize HR control ivabradine might improve clinical , hemodynamic neurohormonal parameter patient DHF . The aim study evaluate efficacy HR control ivabradine patient DHF .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Sinus node rhythm HR &gt; 80 bpm Hospitalization DHF Ejection fraction â‰¤ 40 % Sign inform consent Systolic blood pressure &lt; 85 mmHg Signs hypoperfusion Dobutamine &gt; 15 mcg/Kg/min Acute myocarditis Primary valvular disease require surgery Stroke last three month Hypertrophic restrictive cardiomyopathy Sinus node disease Atrial fibrillation flutter Second third degree atrioventricular blockade Long QT syndrome Severe pulmonary disease Pulmonary embolism last three month Need invasive ventilatory support Septicemia septic shock Hepatic failure Creatinine &gt; 2.5 mg/dL Hemodialysis Advanced malignancy Pregnancy lactation Immunosuppressive therapy Use cytochrome P450 inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ivabradine</keyword>
	<keyword>heart rate</keyword>
	<keyword>heart failure</keyword>
</DOC>